AtriCure (ATRC)
(Delayed Data from NSDQ)
$32.03 USD
+1.63 (5.36%)
Updated Jan 3, 2025 04:00 PM ET
After-Market: $32.03 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth F Momentum B VGM
AtriCure (ATRC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$45.11 | $61.00 | $36.00 | 48.39% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for AtriCure comes to $45.11. The forecasts range from a low of $36.00 to a high of $61.00. The average price target represents an increase of 48.39% from the last closing price of $30.40.
Analyst Price Targets (9 )
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
AtriCure currently has an average brokerage recommendation (ABR) of 1.11 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.11 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, eight are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 88.89% and 11.11% of all recommendations. A month ago, Strong Buy made up 88.89%, while Buy represented 11.11%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.11 | 1.11 | 1.11 | 1.11 | 1.11 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/30/2024 | UBS | Danielle Antalffy | Strong Buy | Strong Buy |
10/30/2024 | Needham & Company | Michael Matson | Moderate Buy | Moderate Buy |
10/30/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/1/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
9/9/2024 | JMP Securities | David L Turkaly | Strong Buy | Strong Buy |
7/31/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
7/31/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.11 |
ABR (Last week) | 1.11 |
# of Recs in ABR | 9 |
Average Target Price | $45.11 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 87 of 251 |
Current Quarter EPS Est: | -0.21 |
ATRC FAQs
AtriCure, Inc. (ATRC) currently has an average brokerage recommendation (ABR) of 1.11 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for AtriCure, Inc. (ATRC) is $45.11. The current on short-term price targets is based on 3 reports.
The forecasts for AtriCure, Inc. (ATRC) range from a low of $36 to a high of $61. The average price target represents a increase of $48.39 from the last closing price of $30.40.
The current UPSIDE for AtriCure, Inc. (ATRC) is 48.39%
Based on short-term price targets offered by nine analysts, the average price target for AtriCure comes to $45.11. The forecasts range from a low of $36.00 to a high of $61.00. The average price target represents an increase of 48.39% from the last closing price of $30.40.